Capital Advisors Inc. OK Buys 554 Shares of Oracle Corporation $ORCL

Capital Advisors Inc. OK increased its holdings in shares of Oracle Corporation (NYSE:ORCL) by 2.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 23,268 shares of the enterprise software provider’s stock after buying an additional 554 shares during the period. Capital Advisors Inc. OK’s holdings in Oracle were worth $5,087,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of ORCL. Brighton Jones LLC grew its stake in shares of Oracle by 189.3% in the 4th quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider’s stock worth $25,593,000 after acquiring an additional 100,494 shares in the last quarter. Revolve Wealth Partners LLC increased its position in shares of Oracle by 8.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider’s stock worth $903,000 after purchasing an additional 404 shares during the last quarter. Sivia Capital Partners LLC grew its position in Oracle by 5.0% during the first quarter. Sivia Capital Partners LLC now owns 3,580 shares of the enterprise software provider’s stock valued at $501,000 after acquiring an additional 171 shares during the last quarter. UMB Bank n.a. grew its holdings in shares of Oracle by 1.0% in the first quarter. UMB Bank n.a. now owns 215,074 shares of the enterprise software provider’s stock worth $30,069,000 after purchasing an additional 2,217 shares during the last quarter. Finally, Whitaker Myers Wealth Managers LTD. bought a new stake in Oracle in the first quarter valued at $515,000. Institutional investors own 42.44% of the company’s stock.

Insiders Place Their Bets

In other news, insider Michael D. Sicilia sold 33,845 shares of the firm’s stock in a transaction that occurred on Tuesday, September 23rd. The stock was sold at an average price of $321.16, for a total value of $10,869,660.20. Following the completion of the sale, the insider directly owned 132,656 shares of the company’s stock, valued at $42,603,800.96. This trade represents a 20.33% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William G. Parrett sold 11,500 shares of the firm’s stock in a transaction that occurred on Friday, September 12th. The shares were sold at an average price of $306.00, for a total value of $3,519,000.00. Following the completion of the transaction, the director directly owned 17,764 shares of the company’s stock, valued at $5,435,784. The trade was a 39.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 104,314 shares of company stock valued at $31,272,223 over the last 90 days. 40.90% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages have commented on ORCL. Weiss Ratings reissued a “hold (c+)” rating on shares of Oracle in a research report on Saturday, September 27th. Cowen reissued a “buy” rating and issued a $375.00 price target on shares of Oracle in a report on Wednesday, September 10th. Stifel Nicolaus increased their price target on Oracle from $250.00 to $350.00 and gave the company a “buy” rating in a report on Wednesday, September 10th. Bank of America raised Oracle from a “neutral” rating to a “buy” rating and increased their price target for the stock from $295.00 to $368.00 in a research report on Wednesday, September 10th. Finally, Redburn Partners set a $175.00 price objective on Oracle in a research note on Thursday, September 25th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-five have assigned a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, Oracle has a consensus rating of “Moderate Buy” and an average target price of $304.71.

Oracle Price Performance

NYSE:ORCL opened at $286.23 on Monday. Oracle Corporation has a 52 week low of $118.86 and a 52 week high of $345.72. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33. The stock’s fifty day moving average is $262.53 and its two-hundred day moving average is $205.85. The company has a market capitalization of $815.99 billion, a P/E ratio of 66.26, a P/E/G ratio of 3.08 and a beta of 1.53.

Oracle (NYSE:ORCL) last released its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing the consensus estimate of $1.48 by ($0.01). The company had revenue of $14.93 billion for the quarter, compared to analyst estimates of $15.04 billion. Oracle had a return on equity of 72.93% and a net margin of 21.08%.The company’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.39 earnings per share. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Equities analysts expect that Oracle Corporation will post 5 EPS for the current year.

Oracle Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 23rd. Shareholders of record on Thursday, October 9th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Thursday, October 9th. Oracle’s dividend payout ratio (DPR) is presently 46.30%.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.